• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Aimei Health Technology Co. Ltd

    3/8/24 4:01:48 PM ET
    $AFJK
    Get the next $AFJK alert in real time by email
    SC 13G 1 ea0201269-13gwealth_aimei.htm SCHEDULE 13G

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

     

    Aimei Health Technology Co., Ltd

    (Name of Issuer)

     

    Ordinary Shares, par value $0.0001 per share

    (Title of Class of Securities)

     

    G01341109

    (CUSIP Number)

     

    February 29, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☒ Rule 13d-1(b)
    ☐ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. G01341109 13G Page 2 of 6

     

      1.

    Names of Reporting Person:

    Wealthspring Capital LLC

      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ☐
        (b) ☒
      3. SEC Use Only  
      4. Citizenship or Place of Organization
    Delaware

    Number of
    Shares
    Beneficially
    Owned by
    Each Reporting
    Person With
    5. Sole Voting Power 0
    6. Shared Voting Power 914,798
    7. Sole Dispositive Power 0
    8. Shared Dispositive Power 914,798

      9. Aggregate Amount Beneficially Owned by Each Reporting Person 914,798
      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
    ☐
      11.

    Percent of Class Represented by Amount in Row (9)

    13.3%

      12.

    Type of Reporting Person (See Instructions)                      IA; PN

     

     

     

     

    CUSIP No. G01341109 13G Page 3 of 6

     

      1.

    Names of Reporting Person:

    Matthew Simpson

      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ☐
        (b) ☒
      3. SEC Use Only  
      4. Citizenship or Place of Organization
    United States of America

    Number of
    Shares
    Beneficially
    Owned by
    Each Reporting
    Person With
    5. Sole Voting Power 0
    6. Shared Voting Power

    914,798

    7. Sole Dispositive Power 0
    8. Shared Dispositive Power 914,798

      9. Aggregate Amount Beneficially Owned by Each Reporting Person

    914,798

      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
    ☐
      11.

    Percent of Class Represented by Amount in Row (9)

    13.3%

      12.

    Type of Reporting Person (See Instructions)                      IN; IA; HC

     

     

     

      

    CUSIP No. G01341109 13G Page 4 of 6

     

    Item 1.

     

    (a)Name of Issuer.

     

    Aimei Health Technology Co., Ltd

     

    (b)Address of Issuer’s Principal Executive Offices.

     

    10 East 53rd Street, Suite 3001

    New York, NY 10022

     

    Item 2.

     

    (a)-(c)Name of Persons Filing, Address of Principal Business Office, Citizenship

     

    This statement is being jointly filed by the following persons (each a “Reporting Person” and, collectively, the “Reporting Persons”). The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than the securities actually owned by such person (if any).

     

    (i)Wealthspring Capital LLC, a Delaware limited liability company (“Wealthspring”); and

     

    (ii)Matthew Simpson, who is a United States citizen and a manager of Wealthspring.

     

    The principal business address for Wealthspring and for Mr. Simpson is 2 Westchester Park Drive, Suite 108, West Harrison, NY 10604.

     

    (d)Title and class of securities covered by this statement:

     

    Ordinary Shares, par value $0.0001 per share (“Shares”)

     

    (e)CUSIP Number:

     

    G01341109

     

    Item 3.

     

    If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

    ☐Broker or dealer registered under section 15 of the Act;

     

    ☐Bank as defined in section 3(a)(6) of the Act;

     

    ☐Insurance company as defined in section 3(a)(19) of the Act;

     

    ☐Investment company registered under section 8 of the Investment Company Act of 1940;

     

    ☒An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     

    ☐An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

     

    ☒A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

     

    ☐A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act;

     

     

     

     

    CUSIP No. G01341109 13G Page 5 of 6

     

    ☐A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

     

    ☐A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);

     

    ☐Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: ________

     

    Item 4. Ownership

     

    (a)Each of Wealthspring Capital LLC and Mr. Simpson may be deemed to beneficially own 914,798 Shares.

     

    (b)The number of Shares that each of Wealthspring Capital LLC and Mr. Simpson may be deemed to beneficially own constitutes approximately 13.3% of the Shares outstanding.

     

    (c)Number of Shares as to which such person has

     

    (i)Sole power to vote or direct the vote:           0

     

    (ii)Shared power to vote or direct the vote:      914,798

     

    (iii)Sole power to dispose or to direct the disposition of:     0

     

    (iv)Shared power to dispose or to direct the disposition of:      914,798

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☐

     

    Item 6. Ownership of More Than 5 Percent on Behalf of Another Person.

     

    Wealthspring Capital LLC’s clients have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported on this statement. No one other person’s interest in the securities reported herein is more than 5%.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company or Control Person.

     

    Not applicable.

     

    Item 8. Identification and Classifications of Members of the Group

     

    Not applicable.

     

    Item 9. Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10. Certification

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    CUSIP No. G01341109 13G Page 6 of 6

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: March 8, 2024

     

    Wealthspring Capital LLC    
         
    By: /s/ Matthew Simpson   /s/ Matthew Simpson
    Name:  Matthew Simpson   Matthew Simpson
    Its: Manager    

     

     

     

     

    EXHIBIT INDEX

     

    Exhibit No.   Description
    99.1   Joint Filing Agreement, dated as of March 8, 2024 by and among Wealthspring Capital LLC and Matthew Simpson.

     

     

     

     

     

    Get the next $AFJK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AFJK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AFJK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Mizuho Securities Usa Llc sold $1,629,000 worth of shares (150,000 units at $10.86), decreasing direct ownership by 21% to 550,387 units (SEC Form 4)

      4 - Aimei Health Technology Co., Ltd. (0001979005) (Issuer)

      2/11/25 2:52:51 PM ET
      $AFJK
    • New insider Mizuho Securities Usa Llc claimed ownership of 700,387 shares (SEC Form 3)

      3 - Aimei Health Technology Co., Ltd. (0001979005) (Issuer)

      2/11/25 2:47:37 PM ET
      $AFJK

    $AFJK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Aimei Health Technology Co. Ltd

      SC 13G/A - Aimei Health Technology Co., Ltd. (0001979005) (Subject)

      11/14/24 5:52:48 PM ET
      $AFJK
    • SEC Form SC 13G filed by Aimei Health Technology Co. Ltd

      SC 13G - Aimei Health Technology Co., Ltd. (0001979005) (Subject)

      11/14/24 1:54:33 PM ET
      $AFJK
    • Amendment: SEC Form SC 13G/A filed by Aimei Health Technology Co. Ltd

      SC 13G/A - Aimei Health Technology Co., Ltd. (0001979005) (Subject)

      11/13/24 4:00:31 PM ET
      $AFJK

    $AFJK
    SEC Filings

    See more
    • Aimei Health Technology Co. Ltd filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)

      6/6/25 8:00:54 AM ET
      $AFJK
    • SEC Form 10-Q filed by Aimei Health Technology Co. Ltd

      10-Q - Aimei Health Technology Co., Ltd. (0001979005) (Filer)

      5/14/25 4:45:19 PM ET
      $AFJK
    • Amendment: SEC Form SCHEDULE 13G/A filed by Aimei Health Technology Co. Ltd

      SCHEDULE 13G/A - Aimei Health Technology Co., Ltd. (0001979005) (Subject)

      5/13/25 6:45:56 AM ET
      $AFJK

    $AFJK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • United Hydrogen Group Inc., a Comprehensive Hydrogen Solution Company in China, Announces Execution of Business Combination Agreement with Aimei Health Technology Co., Ltd to Become a Publicly Traded Company on Nasdaq

       ●United Hydrogen Group Inc. is a comprehensive hydrogen solution company covering hydrogen energy producing, storage and transportation, hydrogen equipment, and hydrogen logistic applications, helping clients fulfill their zero carbon business targets.    ●United Hydrogen Group Inc. generated revenue of approximately US$13.1 million in 2023 (unaudited). Revenue in 2023 increased by 144% compared to revenue in 2022.    ●The proposed transaction values the combined company at an estimated enterprise value on a pro-forma basis of approximately US$1.6 billion, assuming no redemptions by Aimei Health Technology Co., Ltd's shareholders.    Shanghai, China, June 20, 2024 (GLOBE NEWSWIRE) -- Unit

      6/20/24 7:00:00 AM ET
      $AFJK